This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Siemens Medical Solutions USA, Inc., Eli Lilly and Company. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 2,143 
1 out of 4,514 
Years Active: 2013-2026
Title: The Innovative Contributions of Chul Yu
Introduction
Chul Yu is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of medical imaging. With a total of 8 patents, he has made remarkable advancements in the development of imaging agents that target prostate-specific membrane antigen (PSMA). His work has the potential to enhance diagnostic capabilities in the medical field.
Latest Patents
Chul Yu's latest patents focus on PSMA imaging agents, which include compounds for targeting and agents for imaging. These patents disclose methods for synthesizing compounds and imaging agents, as well as techniques for imaging PSMA. The imaging agents developed are suitable for both PET and SPECT imaging, showcasing their versatility and importance in medical diagnostics.
Career Highlights
Throughout his career, Chul Yu has worked with notable companies such as Siemens Medical Solutions USA, Inc. and Eli Lilly and Company. His experience in these organizations has contributed to his expertise in the field of medical imaging and innovation.
Collaborations
Chul Yu has collaborated with esteemed colleagues, including Umesh B Gangadharmath and Joseph C Walsh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in technology.
Conclusion
Chul Yu's innovative work in the development of PSMA imaging agents has significantly impacted the field of medical diagnostics. His contributions continue to pave the way for advancements in imaging technology, ultimately benefiting patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile